Ratings DENTSPLY SIRONA Inc.

Equities

XRAY

US24906P1093

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
28.29 ^USD	-0.32%		-7.46%	-20.51%

May. 03	Evercore ISI Adjusts Dentsply Sirona Price Target to $35 From $40, Maintains Outperform Rating	MT
May. 03	UBS Adjusts Price Target on Dentsply Sirona to $37 From $38, Maintains Buy Rating	MT

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The group shows a rather high level of debt in proportion to its EBITDA.
The company benefits from high valuations in earnings multiples.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	ESG Refinitiv
DENTSPLY SIRONA INC.	-20.51%	5.87B	B-
ABBOTT LABORATORIES	-3.79%	184B	C+
MEDTRONIC PLC	-0.84%	108B	C
BECTON, DICKINSON AND COMPANY	-3.75%	67.82B	A
DEXCOM, INC.	+3.45%	51.05B	B-
CENCORA, INC.	+9.04%	44.67B	B-
HOYA CORPORATION	+3.40%	41.78B	B+
METTLER-TOLEDO INTERNATIONAL, INC.	+3.21%	26.78B	B
WEST PHARMACEUTICAL SERVICES, INC.	+3.66%	26.59B	A-
TERUMO CORPORATION	+15.23%	25.86B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes